Non-Coding RNAs: lncRNA, piRNA, and snoRNA as Robust Plasma Biomarkers of Alzheimer’s Disease
Open Access
- 3 June 2025
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 15 (6) , 806
Abstract
Alzheimer’s disease (AD) is a leading cause of dementia worldwide. As current diagnostic approaches remain limited in sensitivity and accessibility, there is a critical need for novel, non-invasive biomarkers aiding early detection. Non-coding RNAs (ncRNAs), including long non-coding RNAs (lncRNAs), PIWI-interacting RNAs (piRNAs), and small nucleolar RNAs (snoRNAs), have emerged as promising candidates due to their regulatory roles in gene expression and association with diseases. In this study, we systematically profiled ncRNA expression from RNA sequencing data of 48 AD and 22 control blood tissue samples, aiming to evaluate their utility as biomarkers for AD classification. Differential expression analysis revealed widespread dysregulation of lncRNAs and piRNAs, with over 5000 lncRNAs and nearly 1000 piRNAs significantly upregulated in AD. Weighted gene co-expression network analysis (WGCNA) identified multiple ncRNA modules associated with the AD phenotype. Using supervised machine learning approaches, we evaluated the diagnostic potential of ncRNA expression profiles, including single-gene, multi-gene, and module-level models. Random Forest models trained on individual genes identified 121 ncRNAs with AUROC > 0.8. Feature importance analysis emphasized ncRNAs such as lnc-MYEF2-3, lnc-PRKACB2, and HBII-115 as major contributors to diagnostic accuracy. These findings support the potential of ncRNA signatures as reliable and non-invasive biomarkers for AD diagnosis.Keywords
Funding Information
- University of California, San Diego (RG104647)
This publication has 29 references indexed in Scilit:
- Identification of RN7SK LncRNA as a novel biomarker in Alzheimer’s disease using bioinformatics and expression analysisScientific Reports, 2024
- Highly accurate blood test for Alzheimer’s disease is similar or superior to clinical cerebrospinal fluid testsNature Medicine, 2024
- Long non-coding RNAs: definitions, functions, challenges and recommendationsNature Reviews Molecular Cell Biology, 2023
- Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer's diseaseNeurobiology of Disease, 2021
- Analyzing large Alzheimer's disease cognitive datasets: Considerations and challengesAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2020
- A combined miRNA–piRNA signature to detect Alzheimer’s diseaseTranslational Psychiatry, 2019
- Noncoding RNAs in Alzheimer's diseaseWIREs RNA, 2018
- Transcriptome-wide piRNA profiling in human brains of Alzheimer's diseaseNeurobiology of Aging, 2017
- Noncoding RNAs in neurodegenerationNature Reviews Neuroscience, 2017
- Genome-wide significant, replicated and functional risk variants for Alzheimer’s diseaseJournal of Neural Transmission, 2017